At this time, posts about Isu Abxis are rapidly increasing on portals and stock communities. Today, foreigners have net sold 32,000 shares of Isu Abxis, and institutions have net sold 143,000 shares, according to provisional data. Isu Abxis is a subsidiary of the Isu Group, known for developing antibiotic treatments and providing medical services.


As of 1:30 PM on the 10th, the stock price of Isu Abxis rose 29.61% from the previous day to 10,900 KRW, with a trading volume of 18,456,708 shares, which is 1,525.72% of the 5-day average trading volume.


In addition to Isu Abxis, posts by investors are also surging for Devsisters (194480), Kinemaster (139670), and Ssangyong Information & Communications (010280).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing